3rd Quarter - Report

W STRATEGIES, LLC for ABBOTT LABORATORIES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

P.L. 112-144, The Food and Drug Administration Safety and Innovation Act of 2012. Federal legislative efforts to enhance the security and integrity of the domestic pharmaceutical distribution system.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

H.R. 6446: To create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6446 (112th)

Budget/Appropriations BUD

H.J.Res. 117: Continuing Appropriations Resolution for Fiscal Year 2013.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.J.Res. 117 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.